Articles about Product Safety

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast ↗

Today 13:44 EST

Via Benzinga

Nio Recalls 246K EVs For 'Screen Blackouts' As Firm Hits First-Ever Profit Milestone ↗

Today 13:15 EST

Via Benzinga

Why Novo Nordisk Stock Just Popped ↗

Today 12:59 EST

Via The Motley Fool

Why Hims & Hers Stock Just Got Destroyed ↗

Today 12:02 EST

Via The Motley Fool

FDA "Swift Action" Warning Sends Hims & Hers into a Tailspin ↗

Today 4:30 EST

Via Chartmill

The GLP-1 Gold Rush Hits a Wall: Novo Nordisk Sues Hims & Hers as FDA Crackdown Triggers 20% Stock Crash

Today 11:35 EST

Via MarketMinute

FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains ↗

Today 11:21 EST

Via Stocktwits

Why Eli Lilly Stock Just Popped ↗

Today 11:05 EST

Via The Motley Fool

Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit ↗

Today 10:22 EST

Via Investor's Business Daily

The GLP-1 Gold Rush Hits a Wall: Hims & Hers Shares Crater After Abrupt Oral Wegovy U-Turn

Today 10:19 EST

Via MarketMinute

Intuitive Surgical’s New Heart: Analyzing the da Vinci 5 Cardiac Clearance and the Future of Robotic Surgery

Today 10:05 EST

Via Finterra

Cata-Kor Receives NSF Certification for NMN Longevity Formulation

Today 9:56 EST

Via Newsfile

Anavex (AVXL) Q1 2026 Earnings Call Transcript ↗

Today 9:48 EST

Via The Motley Fool

Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination

Today 9:39 EST

Via Finterra

The GLP-1 Reckoning: Why Hims & Hers (HIMS) Pivoted and Shed 20% of Its Value

Today 9:36 EST

Via Finterra

Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks ↗

Today 7:36 EST

Via Stocktwits

Nasdaq, S&P 500 Futures Mixed As Earnings, Data-Heavy Week Loom: Why HIMS, WMT, TSLA, PONY, TGTX Are On Traders' Radar Today ↗

Today 4:28 EST

Via Stocktwits

HIMS Stock In Turmoil: Retail Bulls Bet On Rebound, Skeptics See Bloodbath After Compounded Weight-Loss Pill Halt ↗

February 08, 2026

Via Stocktwits

Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning ↗

February 08, 2026

Via Benzinga

Hims & Hers Health Stops Offering Wegovy Pill Knockoff Over FDA Crackdown ↗

February 07, 2026

Via Investor's Business Daily

This $4 Stock Could Be Your Ticket to Millionaire Status ↗

February 07, 2026

Via The Motley Fool

This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗

February 07, 2026

Via The Motley Fool

PM Q4 Deep Dive: Smoke-Free Product Momentum and Regulatory Hurdles Shape Outlook

February 07, 2026

Via StockStory

AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology

February 06, 2026

Via TokenRing AI

AI’s ‘Penicillin Moment’: How Generative Models Are Slashing Decades of Antibiotic Research into Months

February 06, 2026

Via TokenRing AI

Sweet Recovery: Hershey Shares Surge 9% as Earnings Beat and Bullish Outlook Signal a Turnaround for the Snacking Giant

February 06, 2026

Via MarketMinute

The $49 Disruptor: Hims & Hers Ignites a Brutal Price War in the Weight-Loss Drug Market

February 06, 2026

Via MarketMinute

What's Going On With Novo Nordisk Stock On Friday? ↗

February 06, 2026

Via Benzinga

Why Shares of Novo Nordisk Stock Collapsed This Week ↗

February 06, 2026

Via The Motley Fool

The Trillion-Dollar Divergence: Eli Lilly Hits Milestone While Novo Nordisk Faces 'Supply Chain Reset'

February 06, 2026

Via MarketMinute

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.